Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention

作者: Alexandra M. Fajardo , Gary A. Piazza

DOI: 10.1152/AJPGI.00101.2014

关键词:

摘要: Colorectal cancer (CRC) is one of the most common human malignancies and a leading cause cancer-related deaths in developed countries. Identifying effective preventive strategies aimed at inhibiting development progression CRC critical for reducing incidence mortality this malignancy. The prevention carcinogenesis by anti-inflammatory agents including nonsteroidal drugs (NSAIDs), selective cyclooxygenase-2 (COX-2) inhibitors, natural products an area considerable interest research. Numerous have been identified as potential chemopreventive but vary their mechanism action. This review will discuss molecular mechanisms being studied activity NSAIDs (i.e., aspirin, sulindac, ibuprofen), COX-2 inhibitors celecoxib), curcumin, resveratrol, EGCG, genistein, baicalein), metformin. A deeper understanding how these inhibit provide insight into potentially safer more drugs.

参考文章(136)
Quyen Chu, Tannaz Armaghany, Glenn Mills, Jon D Wilson, Genetic alterations in colorectal cancer. Gastrointestinal cancer research : GCR. ,vol. 5, pp. 19- 27 ,(2012)
Lucas Waltzer, Mariann Bienz, The control of beta-catenin and TCF during embryonic development and cancer. Cancer and Metastasis Reviews. ,vol. 18, pp. 231- 246 ,(1999) , 10.1023/A:1006321324190
Fabio Cianchi, Camillo Cortesini, Ornella Fantappiè, Luca Messerini, Nicola Schiavone, Alfredo Vannacci, Silvia Nistri, Iacopo Sardi, Gianna Baroni, Cosimo Marzocca, Federico Perna, Roberto Mazzanti, Paolo Bechi, Emanuela Masini, Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. American Journal of Pathology. ,vol. 162, pp. 793- 801 ,(2003) , 10.1016/S0002-9440(10)63876-X
Hector W. Alila, Clinton J. Grubbs, John R. Fetter, Isao Eto, William E. Gresh, Andres J. Klein-Szanto, W. Joseph Thompson, Li Liu, Clark M. Whitehead, Daniel R. Farnell, Gary A. Piazza, Rifat Pamukcu, Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis. Cancer Research. ,vol. 61, pp. 3961- 3968 ,(2001)
David S. Alberts, Nancy Shipp Paranka, Gerhard Sperl, Mary Krutzsch, Alanna L. Kulchak Rahm, Paul H. Gross, Dennis J. Ahnen, Randall W. Burt, Klaus Brendel, Gary A. Piazza, Rifat Pamukcu, Antineoplastic Drugs Sulindac Sulfide and Sulfone Inhibit Cell Growth by Inducing Apoptosis Cancer Research. ,vol. 55, pp. 3110- 3116 ,(1995)
Ronald A. Lubet, Gary J. Kelloff, Chinthalapally V. Rao, Vernon E. Steele, Bandaru S. Reddy, Toshihiko Kawamori, Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process. Cancer Research. ,vol. 59, pp. 3387- 3391 ,(1999)
Zoran Gatalica, Marco A. Velasco, Alan P. Fields, Yesim Gökmen-Polar, Nicole R. Murray, Elevated Protein Kinase C βII Is an Early Promotive Event in Colon Carcinogenesis Cancer Research. ,vol. 61, pp. 1375- 1381 ,(2001)
Nancy S. Paranka, Rajendra G. Mehta, Dennis J. Ahnen, Junxuan Lu, Henry J. Thompson, Cheng Jiang, Gary A. Piazza, Rifat Pamukcu, Sulfone Metabolite of Sulindac Inhibits Mammary Carcinogenesis Cancer Research. ,vol. 57, pp. 267- 271 ,(1997)
Andrea Oeckinghaus, Matthew S Hayden, Sankar Ghosh, Crosstalk in NF-κB signaling pathways Nature Immunology. ,vol. 12, pp. 695- 708 ,(2011) , 10.1038/NI.2065
Hong Chen, Zuguang Wang, Genistein Increases Gene Expression by Demethylation of WNT5a Promoter in Colon Cancer Cell Line SW1116 Anticancer Research. ,vol. 30, pp. 4537- 4545 ,(2010)